Plasmablastic lymphoma (PbL) is a rare and aggressive B-cell malignancy with large
neoplastic cells, most of them resembling plasmablasts that have a CD20-negative …

This two-part review aims to present a current and comprehensive understanding of the
diagnosis and management of plasmablastic lymphoma. The first section, as presented in …

Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with
a dismal prognosis despite aggressive therapies. New approaches are needed for those …

Introduction: Plasmablastic lymphoma (PBL) is a rare variant of diffuse large B-cell
lymphoma for which no optimal treatment has been established and prognosis remains …

Plasmablastic lymphoma (PBL) is a rare distinct subtype of aggressive diffuse large B-cell
lymphoma and a notoriously hard to treat entity with a dismal prognosis in both HIV-negative …

Plasmablastic lymphoma (PBL) is a rare and aggressive hematological malignancy. PBL
commonly occurs in immune incompetent patients, such as those with human …

Background: Plasmablastic lymphoma (PBL) is an uncommon variant of diffuse large B-cell
lymphoma that is characterized by its plasmacytoid features, aggressive tendencies, and …

Plasmablastic Lymphoma is a rare large B-cell lymphoma with unique immunohistochemical
and morphological features. It was most commonly associated with HIV infection; however …

Plasmablastic lymphoma is a rare subtype of large B-cell lymphoma characterised by an
aggressive clinical course with frequent relapses and refractoriness to chemotherapy. It is …

Myeloid sarcoma usually involves lymph nodes, and head and neck regions. Uncommon
sites like testis and ovary are rarely involved and pose a diagnostic challenge. Nonspecific …